We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Arranta

News List

Inceptor Bio Acquires Arranta Bio’s Gainesville, FL GMP Facility ContractPharma
November 01, 2021
Inceptor Bio has entered an agreement to acquire Arranta Bio’s 29,000 square foot process development and GMP clinical manufacturing facility and the transfer of a core operating team to establish cell therapy...
Arranta Bio Invests in New Manufacturing Facility contractpharma
March 10, 2021
Addition of 130,000 sq. ft. Boxborough, MA, manufacturing facility to supply clinical and commercial microbiome products.
Arranta Bio Establishes Commercial-Ready Manufacturing Facility contractpharma
September 30, 2020
Arranta Bio, a microbiome contract development and manufacturing organization (CDMO), has announced the mechanical completion of GMP suites at its Watertown, MA commercial-ready facility.
Arranta Bio Expands Microbiome Capacity at CoE contractpharma
May 29, 2020
Adds additional early-clinical GMP capacity for microbiome process development and early clinical supply at Gainesville, FL site.